Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subjects (Q44741688)

5 December 2017

title

Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subjects (English)

1 reference

5 December 2017

4

1 reference

5 December 2017

Heikki A Koistinen

1

1 reference

5 December 2017

Margareta Forsgren

series ordinal

2

1 reference

5 December 2017

Harriet Wallberg-Henriksson

series ordinal

3

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

12

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

25-31

1 reference

Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

CAP defines a second signalling pathway required for insulin-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Life without white fat: a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Tissue-specific dysregulation of cortisol metabolism in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Postprandial lipid metabolism in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Regulation of gene expression by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.5

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.5

1 reference

5 December 2017

1 reference